Ultragenyx Pharmaceutical Inc.【RARE】業績推移・財務諸表

（単位：千ドル）	1Q14	2Q14	3Q14	4Q14	1Q15	2Q15	3Q15	4Q15	1Q16	2Q16	3Q16	4Q16	1Q17	2Q17	3Q17	4Q17	1Q18	2Q18	3Q18	4Q18	1Q19	2Q19	3Q19	4Q19	1Q20	2Q20	3Q20	4Q20	1Q21	2Q21	3Q21	1Q22	2Q22	3Q22	1Q23	2Q23	3Q23	1Q24	2Q24	3Q24	1Q25
売上高	93	149	-	-	-	-	-	-	-	17	111	5	-	-	198	2,414	10,677	12,794	11,763	16,261	18,172	24,149	25,800	35,593	36,309	61,709	81,470	91,542	99,395	86,975	81,647	79,935	89,343	90,703	100,496	108,309	98,052	108,833	147,026	139,494	139,292
売上成長率（％）	-	-	-	-	-	-	-	-	-	-	-	-	-	-			-	-
売上原価	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	225	141	273	-	452	766	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
研究開発費	8,353	11,239	12,854	-	17,364	23,104	29,704	-	40,415	43,332	48,711	-	51,269	58,436	60,412	-	75,504	76,835	70,041	-	78,105	96,045	100,144	-	112,961	80,709	87,314	-	147,518	113,205	113,417	143,155	154,529	237,297	165,698	164,949	157,245	178,487	161,503	170,109	165,772
販売管理費	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	31,435	30,718	31,095	-	38,829	39,812	41,006	-	47,516	42,252	42,123	-	53,258	53,410	53,883	67,312	68,137	69,841	76,646	81,403	74,917	78,160	80,604	80,351	87,797
営業費用	10,339	13,661	15,835	16,943	21,502	30,142	39,936	56,158	53,622	58,070	65,894	70,554	69,954	78,441	83,911	99,248	107,164	107,694	101,409	106,601	117,386	136,623	143,833	130,045	156,974	124,764	131,785	187,623	205,964	169,751	-	-	-	-	-	-	-	-	-	-	-
営業利益	-10,339	-13,661	-15,835	-	-21,502	-30,142	-39,936	-	-53,622	-58,053	-65,783	-	-69,954	-78,441	-83,713	-	-96,487	-94,900	-89,646	-	-99,214	-112,474	-118,033	-	-120,665	-63,055	-50,315	-	-106,569	-82,776	-89,828	-136,632	-141,593	-225,066	-154,105	-147,957	-145,097	-165,347	-116,361	-131,987	-142,939
営業利益率 (%)			-	-	-	-	-	-	-			-	-	-		-				-				-				-
経常（税引前）利益	-	-	-	-	-	-	-	-	-	-	-	-	-	-72,877	-79,223	-	30,292	-52,626	-87,063	-	-96,540	-98,959	-112,701	-	-118,616	25,730	-68,532	-	-135,762	-121,965	-72,816	-151,762	-157,860	-238,819	-163,477	-159,096	-158,999	-170,229	-130,740	-133,213	-149,770
経常（税引前）利益率（％）	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-40011.62	-	283.71	-411.33	-740.14	-	-531.26	-409.79	-436.83	-	-326.68	41.7	-84.12	-	-136.59	-140.23	-89.18	-189.86	-176.69	-263.3	-162.67	-146.89	-162.16	-156.41	-88.92	-95.5	-107.52
法人税等合計	-	-	-	-	-	-	-	-	-	-	-	-	-	14	4	-	39	102	247	-	216	213	293	-	409	415	313	-	379	463	182	558	302	6,287	495	732	650	455	858	303	1,310
実効税率（％）	-	-	-	-	-	-	-	-	-	-	-	-	-			-				-				-				-
純利益	-13,630	-13,585	-15,849	-16,738	-21,379	-29,787	-39,232	-55,220	-52,757	-56,923	-64,907	-	-68,290	-72,891	-79,227	-81,731	30,253	-52,728	-87,310	-87,826	-96,756	-99,172	-112,994	-93,805	-119,025	25,315	-68,845	-24,011	-136,141	-122,428	-72,998	-152,320	-158,162	-245,106	-163,972	-159,828	-159,649	-170,684	-131,598	-133,516	-151,080
純利益率（％）			-	-	-	-	-	-	-			-	-	-
一株あたり利益	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.63	-	-	-	-1.82	-	-	-	-	0.42	-	-	-	-1.81	-	-	-	-3.5	-2.33	-2.25	-2.23	-2.03	-1.52	-1.4	-1.57
希薄化後一株あたり利益	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.62	-	-	-	-1.82	-	-	-	-	0.41	-	-	-	-1.81	-	-	-	-3.5	-2.33	-2.25	-2.23	-2.03	-1.52	-1.4	-1.57
EBITDA		-	-	-		-	-	-		-	-	-		-	-	-		-	-	-		-	-	-		-	-	-		-	-		-	-		-	-		-	-
EBITDAマージン（％）		-	-	-	-	-	-	-	-	-	-	-	-	-	-	-		-	-	-		-	-	-		-	-	-		-	-		-	-		-	-		-	-

Ultragenyx Pharmaceutical Inc.【RARE】 業績推移・財務諸表

Ultragenyx Pharmaceutical Inc.【RARE】業績推移・財務諸表